✦ LIBER ✦

Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511

✍ Scribed by Wetzler, M.; Sanford, B. L.; Kurtzberg, J.; DeOliveira, D.; Frankel, S. R.; Powell, B. L.; Kolitz, J. E.; Bloomfield, C. D.; Larson, R. A.

Book ID: 125525442
Publisher: American Society of Hematology
Year: 2007
Tongue: English
Weight: 82 KB
Volume: 109
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2006-09-045351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nelarabine induces complete remissions i

Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801

✍ DeAngelo, D. J.; Yu, D.; Johnson, J. L.; Coutre, S. E.; Stone, R. M.; Stopeck, A 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 247 KB

Lineage specific treatment of adult pati

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine : Cancer and Leukemia Group B Study 9311

✍ Ted P. Szatrowski; Richard K. Dodge; Carol Reynolds; Carol A. Westbrook; Stanley 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Background: Anti-b4-blocked ricin is an immunotoxin comprised of an anti-cd19 murine monoclonal antibody (b4) conjugated to blocked ricin, which has cytotoxic activity in patients with lymphoid malignancies. ## Methods: Adults with untreated acute lymphoblastic leukemia (all) were treated with

Long-Term Outcome of Treatment With Prot

Long-Term Outcome of Treatment With Protocols AL841, AL851, and ALHR88 in Children With Acute Lymphoblastic Leukemia: Results Obtained by the Kyushu-Yamaguchi Children’s Cancer Study Group

✍ Akinobu Matsuzaki; Eiichi Ishii; Yoshihisa Nagatoshi; Haruhiko Eguchi; Hiroyuki 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 109 KB

An evaluation of combinations of diaziqu

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

✍ Lee, E J; George, S L; Amrein, P C; Paciucci, P A; Allen, S L; Schiffer, C A 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB